In this briefing: The Strait Jacket: Hormuz, OPEC's Fraying Seams & The Shipping Storm That Isn't Going Away Insider Activity: Who Bought Their Own Stock in April 2026 APAC Healthcare Weekly (May 3) – Simcere, Beigene, Otsuka, Kyowa Kirin, Sun Pharma Primer: Dalmia Bharat Sugar and Industries (DCB IN) - May 2026 How Waaree Energies(The Moat Builder) Is Wiring Together India's Entire Solar Stack? 1. The Strait Jacket: Hormuz, OPEC's Fraying Seams & The Shipping Storm That Isn't Going Away This insight provides a summary of webinars of Kpler and Lloyd's List Intelligence and their take on the latest developments in the SOH Hormuz traffic near-freefall (again). Week 17 (Apr 20–26) recorded 36 transits vs. 77 the prior week; the shadow fleet now constitutes over 80% of what little energy still flows through. LPG rates highest since Sept 2023; product tanker rates remain double pre-war levels—freight markets signal tightening of physical crude supply, a reality futures markets have yet to fully price in. 2.

In this briefing: Insider Activity: Who Bought Their Own Stock in April 2026 APAC Healthcare Weekly (May 3) – Simcere, Beigene, Otsuka, Kyowa Kirin, Sun Pharma Primer: Dalmia Bharat Sugar and Industries (DCB IN) - May 2026 How Waaree Energies(The Moat Builder) Is Wiring Together India's Entire Solar Stack? Pakistan Strategy: Soaring Oil Prices Amidst Regional Conflicts; Implication For Pakistan Economy And Market 1. Insider Activity: Who Bought Their Own Stock in April 2026 April 2026 insider activity was weak due to ongoing silent period during earnings season. We highlight large and small cap companies that experienced significant insider buying during April 2026, as reported on the stock exchanges. We also present key sectors which saw insider buying during the month along with names which have moved significantly above the insider buying price. 2. APAC Healthcare Weekly (May 3) – Simcere, Beigene, Otsuka, Kyowa Kirin, Sun Pharma NMPA accepted Simcere’s resubmitted NDA for Rademikibart for the treatment of atopic dermatitis.

In this briefing: APAC Healthcare Weekly (May 3) – Simcere, Beigene, Otsuka, Kyowa Kirin, Sun Pharma Primer: Dalmia Bharat Sugar and Industries (DCB IN) - May 2026 How Waaree Energies(The Moat Builder) Is Wiring Together India's Entire Solar Stack? Pakistan Strategy: Soaring Oil Prices Amidst Regional Conflicts; Implication For Pakistan Economy And Market India's Surgical FDI Move: Getting the Factory, Not Just the Technology 1. APAC Healthcare Weekly (May 3) – Simcere, Beigene, Otsuka, Kyowa Kirin, Sun Pharma NMPA accepted Simcere’s resubmitted NDA for Rademikibart for the treatment of atopic dermatitis. FDA has granted Priority Review to Beigene’s indication expansion application for Tevimra in first-line gastroesophageal adenocarcinoma. FDA has accepted Taiho Pharmaceutical’s NDA for NSCLC drug candidate zipalertinib. Kyowa Kirin and Kura Oncology initiated Japanese Phase 2 registrational clinical trial studying ziftomenib, for acute myeloid leukemia. Sun Pharmaceutical is acquiring Organon for $14 per share in an all‑cash transaction with an enterprise valuation of $12B.

In this briefing: Relative Value Opportunities in Asia-Pac, Pair Trade Roundup (4 May 2026) Primer: Yamaya Corp (9994 JP) - May 2026 Primer: Dalmia Bharat Sugar and Industries (DCB IN) - May 2026 Primer: Kc Feed Co Ltd (025880 KS) - May 2026 Primer: Vedan International Holdings (2317 HK) - May 2026 1. Relative Value Opportunities in Asia-Pac, Pair Trade Roundup (4 May 2026) Context: This Insight follows up on previously highlighted relative value opportunities, using a statistical methodology based on mean-reversion to identify opportunities in paired securities. Highlights: Currently 16 pair trade opportunities persist across four markets and ten sectors. Why read: Statistical analysis offers a unique perspective on relative value. Gain insights into actionable statistical pair trade opportunities and monitor performance of previously highlighted pairs. 2. Primer: Yamaya Corp (9994 JP) - May 2026 Yamaya Corp is a major Japanese retailer of alcoholic beverages and food, operating a dual-segment model of retail stores/mail order and restaurants.

Sugar stocks closed mixed on Friday. Triveni, Avadh Sugar, and Ponni Sugars’ gains were offset by losses in E.I.D Parry, Dalmia Bharat, and Shree Renuka Sugars.

Relaxed export rules and increased diversion for ethanol production could partially offset challenges surrounding pricing. Key players like Balrampur Chini and EID Parry remain on investor watchlists

Infosys, Dr Reddy’s Laboratories, and Tata Consumer Products, among others, are set to report their quarterly earnings later today

Cement and OMC stocks rallied, while broader markets underperformed in a largely sectoral-driven expiry session.

Pan-India prices rose marginally in June, but monsoon onset could disrupt momentum, according to an analyst. Ambuja and ACC may face demand headwinds.